Purchase Order HT940726PE007

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on September 4, 2025, for dry chemistry analyzers at Fort Meade with a ceiling value of $68,679.79. The order covers the ordering period September 1, 2025 through August 31, 2026, with ultimate completion by August 31, 2028. Vendor payment is contingent on actual results delivered on a cost-per-reportable-result basis under firm fixed pricing. Place of performance is Fort Meade, MD. Quidelortho Sales Company is a...

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on July 1, 2022, with a ceiling value of $235,369.70 for lab chemistry analyzer cost-per-test services at 92D Medical Group, Fairchild Air Force Base. The order is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Quidelortho Sales Company, LLC is a HUBZone joint venture. Place of performance is Fairchild Air Force Base, Washington. The order is firm fixed price with an ultimate...

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on October 1, 2025, with a ceiling value of $519,519.30 for laboratory analyzers and reagents, under firm fixed pricing. The order adds FY25 funds to an existing delivery order (W81K0024F0121) to cover overages. Place of performance is Raritan, NJ. Ultimate completion is September 30, 2026. Quidelortho Sales Company is a HUBZone joint venture based in San Diego, California, specializing in medical diagnostic...

The Defense Health Agency has awarded a delivery order contract valued at $352,894.19 to Quidelortho Sales Company, LLC for the provision of two integrated system cost-per-test chemistry analyzers. The contract, which carries a firm fixed-price structure with no set-aside designation, was awarded on December 2, 2025, and is scheduled for completion by April 1, 2027. Performance will take place at Langley Air Force Base, Virginia. This delivery order is issued under the General Services...

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone joint venture, on March 26, 2024, with a ceiling value of $184,561.99 for cost-per-test reagents, equipment, and service and cost-per-test chemistry analyzer support. The order is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Place of performance is Raritan, NJ. The order is firm fixed price with an ultimate completion date of September 30, 2026. No set-aside was used in...

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on September 24, 2022, with a ceiling value of $294,037.83 for chemistry analyzer and laboratory reagents, under the GSA Critical Analyzers, Laboratory (FSS-66-III) master schedule. Quidelortho Sales Company is a HUBZone joint venture based in San Diego, California. Place of performance is Raritan, NJ. The order carries firm fixed pricing and an ultimate completion date of June 30, 2026. No set-aside was used for...

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on February 23, 2022, with a ceiling value of $596,855.85 for immunoassay and chemical analyzer equipment and reagents, with ultimate completion scheduled for February 22, 2027. The order was issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Quidelortho Sales Company is a HUBZone joint venture based in San Diego, California, specializing in medical diagnostic equipment and laboratory...

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on October 1, 2025, with a ceiling value of $2,422,723.10 for lease, supplies, and reagents for a Bach Chemistry Immunoassay Analyzer on a firm fixed-price basis. This delivery order is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Quidelortho Sales Company, LLC is a self-certified HUBZone joint venture. Place of performance is Fort Campbell, KY. The order extends through September...

The Defense Health Agency awarded a $43,965.34 firm fixed-price delivery order to Quidelortho Sales Company, LLC for a chemistry analyzer including reagents. The contract, which carries no set-aside designation, has an ultimate completion date of September 30, 2026, and is positioned within the GSA's Critical Analyzers, Laboratory (FSS-66-III) master schedule framework. Performance will take place at the Naval Support Activity Annapolis, Maryland location. Quidelortho Sales Company, a San...

Quidelortho Sales Company, LLC, a San Diego-based medical diagnostic equipment distributor, was awarded a delivery order by the Defense Health Agency on September 19, 2022, for annual cost-per-test hematology analyzer services. The contract carries a ceiling value of $394,142.75 and is scheduled for ultimate completion on September 29, 2027. This delivery order operates under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) master schedule framework with firm...